- Investing Ideas
- /
- Austrian Pharmaceuticals & Biotech Potentially Undervalued Companies
Austrian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
43
Companies with a Value score of at least 3, ordered by Value score
43 companies
Vertex Pharmaceuticals
Market Cap: €96.6b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTX
€324.40
7D
-1.3%
1Y
-21.7%
Danaher
Market Cap: €129.9b
Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
DHRC
€159.36
7D
-3.5%
1Y
-36.1%
Illumina
Market Cap: €14.5b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
€78.89
7D
-9.4%
1Y
-31.6%
UCB
Market Cap: €37.3b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€200.40
7D
-1.1%
1Y
22.7%
Tilray Brands
Market Cap: €1.4b
A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.
TLRY
€1.02
7D
-0.7%
1Y
-32.6%
Recordati Industria Chimica e Farmaceutica
Market Cap: €10.5b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€51.45
7D
-3.3%
1Y
1.5%
BioNTech
Market Cap: €24.0b
A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.
BNTX
€83.85
7D
-0.2%
1Y
-19.1%